Key result
Biochemical markers, particularly cardiac troponins and natriuretic peptides, play a pivotal role in the diagnosis, risk stratification, and management of patients with cardiac disease.
Why the study?
What is the role of biochemical cardiac markers in the diagnosis and management of acute coronary syndrome and cardiac function assessment?
What is the role of biochemical cardiac markers in the diagnosis and management of acute coronary syndrome and cardiac function assessment?
This review highlights the critical role of cardiac biomarkers like troponins and natriuretic peptides in diagnosing ACS and assessing cardiac function, while noting the need for earlier markers of ischemia.
Answers are grounded in this paper and cite their sources.
Supports ongoing reliance on troponins and natriuretic peptides for ACS; leaves open pursuit of earlier ischemia markers.
Millions of patients present annually with chest pain, but only 10% to 15% have myocardial infarction. Lack of diagnostic sensitivity and specificity of clinical and conventional markers prevents or delays treatment and leads to unnecessary costly admissions. Comparative data are lacking on the new markers, yet using all of them is inappropriate and expensive. The biochemical marker determination to clinical cardiology and discusses some important developments in this field. Biochemical markers play a pivotal role in the diagnosis and management of patients with acute coronary syndrome (ACS), as witnessed by the incorporation of cardiac troponins into new international guidelines for patients with ACS and in the redefinition of myocardial infarction. Despite the success of cardiac troponins, there is still a need for the development of early markers that can reliably rule out ACS from the emergency room at presentation and also detect myocardial ischaemia in the absence of irreversible myocyte injury. The cardiac natriuretic peptides, Laboratory Medicine are also assuming a role in the assessment of cardiac function. Biochemical markers now play an important role in the detection of disease, risk stratification and the monitoring of therapy. Keywords: Biochemical markers, Myocardial infarction, Troponin, Brain natriuretic peptide doi: 10.3329/jom.v10i2.2824 J MEDICINE 2009; 10 : 100-108
No takes yet. Share an insight, caveat, or question.
Pasupathi et al. (1970) conducted a review in Acute coronary syndrome and heart failure. Biochemical cardiac markers was evaluated. Biochemical markers, particularly cardiac troponins and natriuretic peptides, play a pivotal role in the diagnosis, risk stratification, and management of patients with cardiac disease.
Synapse has enriched 10 related papers. Consider them for comparative context: